Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
from humans C07K14/575Hormones Landscapes Health & Medical Sciences (AREA) Chemical & Material Sciences (AREA) Organic Chemistry (AREA) Life Sciences & Earth Sciences (AREA) Biophysics (AREA) Gastroenterology & Hepatology (AREA) Zoology (AREA) Biochemistry (AREA) Toxicology (AREA) General Health & Medical Sciences (AREA) Genetics & Genomics (AREA) Medicinal Chemistry (AREA) Molecular Biology (AREA) Proteomics, Peptides & Aminoacids (AREA) Endocrinology (AREA) Peptides Or Proteins (AREA) Abstract CagrilintideCagrilintide78FmocAlaThr(promeme)OHCagrilintide1011FmocAlaThr(promeme)OHCagrilintide2122FmocSerSer(promeme)OHCagrilintide The invention discloses a method for synthesizing Cagrilintide, comprising the following steps: step 1, selecting the 7-8th amino acid of the Cagrilintide sequence as a pseudo-pro dipeptide Fmoc-Ala-Thr(pro-me-me)-OH, using Cagrilintide The 10-11th amino acid of the sequence is used as the pseudo-pro dipeptide Fmoc-Ala-Thr(pro-me-me)-OH, and the 21-22nd amino acid of the Cagrilintide sequence is used as the pseudo-pro dipeptide Fmoc-Ser-Ser (pro -me-me)-OH
Tucson Wellness MD provides medically guided peptide therapy consultations to help patients review recovery goals, safety concerns, dosage questions, and provider-supervised options
The MedWatch program helps FDA track medication safety issues: Complete and submit the report online
For people with diabetes, glucose readings and low-glucose symptoms should be included when relevant
This article answers the question directly: the right choice depends on your research goal
